Insights

Dr Siegel, from Dartmouth-Hitchcock Medical Center in New Hampshire, reviews the importance of shared decision-making, careful listening, and providing guidance in developing treatment plans for patients with ulcerative colitis.

Dr Regueiro reports from the ACG Scientific Meeting that a study of Janus kinase (JAK) inhibitors for treatment of ulcerative colitis and Crohn's disease provided reassurance of the safety of these small molecules.

Dr Long reviews her presentation from the AIBD regional meeting on using comparative effectiveness data to choose from among the growing number of therapies for treating ulcerative colitis.

Dr Raymond Cross hosts Drs James Lewis and Laura Raffals in a discussion of SPARC, a study of adults with inflammatory bowel disease in which patients are followed prospectively to collect data about to allow prediction of disease course and...

Dr Rubin discusses the results of the maintenance component of the QUASAR study of guselkumab, an IL-23/p19 inhibitor, in the treatment of ulcerative colitis, which he presented at Digestive Disease Week.

Dr Caldera, from the University of Wisconsin School of Medicine, provides an overview of the risks of respiratory syncytial virus to older adults, including patients with IBD, and the importance of ensuring patients receive this vaccine along...

IBD Drive Time Hosts Millie Long, MD, and Raymond Cross, MD, discuss new recommendations for managing inflammatory bowel disease among pregnant patients or those wanting to conceive, resulting from updates to the landmark PIANO study. 

Dr David Hudesman of NYU-Langone Health joins IBD Drive Time host Dr Raymond Cross to talk about how inflammatory bowel disease affects work productivity and social activities.

Dr Gu reviews his address at the AIBD regional meeting on the recurrence of postoperative Crohn's disease, including how to assess risks and steps that can help to prevent it.

Dr Ha stressed that "age is just a number" in her address at the AIBD regional meeting on caring for older patients with IBD, noting that overall health, comorbidities, and many other factors should be weighed when choosing therapies for...